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Abstract
Background: Fibromyalgia (FM) is a prevalent and disabling disorder characterised by widespread pain and other
symptoms such as insomnia, fatigue and depression. Catastrophisation is considered to be a key clinical symptom
in FM; however, few studies have investigated how contextual factors, such as catastrophisation, might contribute
to the duration of the pain. The present research examined the relationship among pain, catastrophic thinking and
FM impact, as a function of stage of chronicity.
Methods: In this cross-sectional study, the sample of 328 patients diagnosed with FM was divided into 3 groups
based on level of chronicity: Group A (6 months to 2 years, N = 46); Group B (2-4 years, N = 59); and Group C
(more than 4 years, N = 223). The three subscales of the Pain Catastrophising Scale (PCS), rumination,
magnification, and helplessness, were used as predictors of dysfunction. The Fibromyalgia Impact Questionnaire
and the McGill Pain Questionnaire were also administered. A hierarchical regression analysis was performed on the
entire sample and, subsequently, for each group to determine the effect of the continuous process variables
(castastrophising and pain) on the stages of chronicity.
Results: Total score and PCS subscales were strongly associated with pain and impact in all the stages of
chronicity in FM patients (r = 0.27-0.73, p < 0.05). For Group A, a regression analysis revealed that rumination
predicted FM impact beyond the variance accounted for by age and pain. Both magnification and helplessness
predicted impact in Group B, and helplessness was a significant predictor of impact in Group C.
Conclusion: These findings provide preliminary evidence that stage of chronicity is an important moderator of
psychological vulnerability for FM impact and should be taken into account by tailoring psychological
interventions.
Background
Fibromyalgia (FM) is defined by the American College
of Rheumatology (ACR) as chronic (>3 months), wide-
spread pain (axial plus upper and lower segment plus
left and right sided pain) and tenderness in at least 11
of 18 tender points [1]. Patients frequently describe sen-
sations of fatigue, sleep disturbances, morning stiffness,
symptoms associated with irritable bowel syndrome and
affective distress. The prognosis for symptomatic recov-
ery is generally poor, and the estimation for lifetime pre-
valence is approximately 2% in community samples
[2,3]. Most patients report a high degree of impairment
in their daily functioning. When compared to patients
with other chronic pain conditions, patients with FM
report higher levels of pain and functional disability and
judge their quality of life as poorer [4]. Moreover, they
make extensive use of health services, thus leading to
high costs for medical and societal care [5]. The syn-
drome’s pathology is not well understood, and to date,
no treatment has proven effective in fully alleviating its
symptoms. A number of meta-analyses and reviews have
been conducted on pharmacological [6,7] and non-phar-
macological [8-10] treatments available for FM.
Psychological treatments seem to have beneficial
short-term effects on the key symptoms of FM, but
these effects largely disappear over the long term. Most
studies to date have addressed the role of psychological
factors in the development of chronic pain following
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any medium, provided the original work is properly cited.acute pain [11,12]. Several psychological constructs have
been associated with the prognosis of FM, such as fear-
avoidance [13], self-efficacy and personal control [14],
pain coping [15] and acceptance [16]. The construct
receiving the most attention currently appears to be cat-
astrophising [17]; this attention may be due to the con-
struct’s association with negative prognosis.
Catastrophising refers to a combination of negative
thoughts and expectations regarding pain, and research
shows that it is a critically important variable in under-
standing the experience of pain in rheumatologic disor-
ders and in other chronic pain conditions. Thus, this
thought process may be an important target for both
psychosocial and pharmacological treatment of pain
[18,19].
Indeed, it has been proposed that the development of
FM involves an interaction between the experience of
pain and catastrophising, but it is unclear when and
how this cognitive construct first becomes important
[20]. Consequently, there is a need to study the relation-
ship between catastrophising and dysfunction in relation
to the development of FM. One approach might be to
use cross-sectional comparisons where different stages
of chronicity provide a proxy for the development
process.
It is also unclear whether the three components of
catastrophising (rumination, magnification, and helpless-
ness) contribute equally to the prediction of dysfunction
in FM or whether certain components are more predic-
tive than others. Information concerning the relative
importance of the components of catastrophising could
help treatment providers to tailor interventions to facili-
tate positive outcomes.
The aim of the present research was to replicate and
extend the findings of Sullivan [21] with regard to FM.
To this end, the present study examined whether the
three components of catastrophising interacted with
chronicity (i.e., the length of time the individual had
been diagnosed with FM) in predicting the severity of
the FM impact (i.e., activity limitations due to pain).
Method
Design
This was a multi-centre, cross-sectional study.
Participants and setting
The study sample consisted of 328 patients from the Pain
Clinic, Santander (Spain) and 8 primary care centres in
Zaragoza (Spain) during the year 2009. To be included in
the study, patients were required to fulfil several inclu-
sion criteria: (1) be between 18 and 65 years old; (2) be
able to understand and read Spanish; (3) meet the ACR
criteria for primary FM [1]; and (4) have been diagnosed
b yaS p a n i s hN a t i o n a lH e a l t hS e r v i c er h e u m a t o l o g i s t .
Exclusion criteria included the following: (1) diagnosis of
a severe Axis I psychiatric disorder (dementia, schizo-
phrenia, paranoid disorder, or abuse of alcohol and/or
drugs) or a severe Axis II disorder that, from the clini-
cian’s point of view, might prevent them from following
the study protocol; and (2) refusal to participate.
Measures
Demographic and Pain-Related Variables
Each participant was interviewed and asked to provide
information about a number of demographic and pain-
related variables, including age, work status, duration of
FM diagnosis, medications and other medical
treatments.
Catastrophising
The PCS is a 13-item scale designed to assess the cata-
strophising cognitions of individuals by asking them to
reflect on thoughts or feelings associated with past pain-
ful experiences [22]. It can be divided into three sub-
scales: rumination, magnification and helplessness. Each
item is scored from 0 (not at all) to 4 (always), and
scores range from 0 to 52. The PCS has good temporal
stability, internal consistency and validity. The Spanish
version of the PCS has been validated by the current
study’s authors and shows psychometric properties simi-
lar to those of the original questionnaire [23].
Pain Severity
The McGill Pain Questionnaire (MPQ) was used as a
measure of pain severity [24]. It consists primarily of
three types of descriptors, sensory words, affective
words and evaluative words, which are used by patients
to specify subjective pain experience. It also contains an
intensity scale and other items to determine the proper-
ties of pain experience. For the purposes of the present
study, the Pain Rating Index was used. The Pain Rating
Index has been recommended as a reliable and valid
measure of chronic pain experience. This instrument
has a translated and validated Spanish version [25].
Fibromyalgia Impact Questionnaire
The Fibromyalgia Impact Questionnaire (FIQ) is a 10-
item self-report questionnaire developed to measure the
health status of FM patients [26]. The first item focuses
on the patient’s ability to carry out muscular activities.
In the next two items, patients are asked to circle the
number of days in the past week they felt good and how
often they missed work. Finally, the last seven questions
(ability to work, pain, fatigue, morning tiredness, stiff-
ness, anxiety, depression) are measured using a visual
analogue scale. This instrument also has a translated
and validated Spanish version[27].
Procedure
The study questionnaires and protocol were approved by
the Ethical Committee of the regional health authority,
Rodero et al. BMC Musculoskeletal Disorders 2010, 11:251
http://www.biomedcentral.com/1471-2474/11/251
Page 2 of 6and the patients signed consent forms attesting to their
willingness to participate. After consenting to the study,
recruited patients were given a battery of questionnaires
to complete. These questionnaires included a pain form
for demographic variables, the FIQ, the PCS and the
MPQ.
Patients were classified into 1 of 3 groups on the basis
of the chronicity of their FM disorder. Patients in
Group A had been diagnosed less than 2 years ago (N =
46), those in Group B had received the diagnosis
between 2 and 4 years ago (N = 59), and the members
of Group C had carried the diagnosis for more than 4
years (N = 223).
Statistical methods
Sample size
There are no previous studies assessing the distribution
of disease chronicity in patients with FM. The large
sample size was chosen to ensure a minimum of 45
patients in each group. Therefore, patients were
recruited from both a tertiary care setting (the Pain
Clinic, Santander; N = 175; 53.3%) and in primary care
centres in Zaragoza (N = 153; 46.7%).
Analysis strategy
In the descriptive analysis of the sample, means and
standard deviations were calculated for continuous vari-
ables (i.e., age and pain), and percentages were calcu-
lated for categorical variables (i.e., gender and treatment
setting). Analysis of variance (ANOVA) was used to
compare the three chronicity groups. Pearson correla-
tions were used to assess the relationship between pain
catastrophising (total score and subscales) and other
psychometric variables such as pain (measured with
MPQ) and impact of FM (measured with FIQ). A hier-
archical regression analysis was performed on the entire
sample to determine the effect of the continuous pro-
cess variables (castastrophising and pain) on FM impact.
All analyses were conducted with SPSS 15.
Results
No patients were rejected because of severe Axis I or
Axis II psychiatric disorder. Only two patients (0.006%)
refused to participate in the study. The study sample
consisted of 328 patients (93.9% women and 6.1% men),
aged 18-77 years (mean 49.5 years, SD: 10.6 years), and
all of them self-described as from the European ethnic
group. On average, the patients had been suffering from
FM for 11.3 years (range 6 months - 40 years), and
22.8% had been granted an invalidity pension.
First, the data were summarised and explored. The
mean scores on the measures were compared across the
stages of chronicity using Pearson Correlation Coeffi-
cients. Mean and standard deviations for demographic
and dependent variables are found in Table 1. Despite
variations across some measures, there were no signi-
ficant differences between groups for age, pain, the
catastrophising subscales or FM impact. Correlations
between the catastrophising subscales and pain and
FM impact are displayed for each chronicity group in
Table 2. In both cases, and in the three groups, catastro-
phising subscales were significantly correlated with pain
and the FM impact.
Following these analyses, the moderational effect of
the stage of chronicity was tested, as in the original
paper [21], using a hierarchical regression analysis. To
test whether stage of chronicity moderated the effect of
the catastrophising components (rumination, magnifica-
tion, and helplessness) on function, the interaction
between catastrophising and stage of chronicity was
added.
Firstly, the hierarchical regression analysis was per-
formed on the entire sample to test whether any of the
interactions between chronicity and the three catastro-
phising components was more predictive of FM impact
than the individual PCS subscales. Age was entered in
Step 1 of the analysis but did not contribute significant
variance. Pain severity was entered in Step 2 and con-
tributed 24% of variance to the prediction of FM impact,
r=0 . 4 8 ,F = 95.9, p < 0.001. The PCS subscales were
entered in Step 3 of the analysis and contributed 8% to
the prediction of impact, r=0 . 5 6 ,F =4 8 . 0 ,p <0 . 0 0 1 .
The three interaction terms were entered in the final
step of the analysis, but they did not contribute any
additional variance to the prediction of FM impact.
Secondly, the nature of interactions was explored with
separate multiple regressions for each level of chronicity.
Pain intensity was used as a covariate in order to
address whether the catastrophising components con-
tributed to the variance in function beyond the variance
accounted for by pain. The results of regression analyses
predicting dysfunction in the three chronicity groups are
presented in Table 3. For Group A, pain was entered in
Table 1 Sample characteristics
Group A
(< 2 years)
Group B
(2-4 years)
Group C
(> 4 years)
Age 47.0 (9.8) 48.3 (11.0) 50.3 (10.5)
MPQ 38.8 (7.9) 40.2 (8.2) 40.9 (8.3)
FIQ 71.3 (16.4) 70.8 (16.5) 73.6 (16.1)
PCS subscales
Rumination 10.4 (4.2) 11.1 (4.1) 11.0 (4.0)
Magnification 6.7 (3.7) 6.6 (3.1) 6.6 (3.1)
Helplessness 13.8 (6.2) 15.4 (5.8) 15.5 (5.6)
PCS total 30.9 (14.3) 33.1 (11.9) 33.1 (11.6)
MPQ = McGill Pain Questionnaire.
FIQ = Fibromyalgia Impact Questionnaire.
PCS = Pain Catastrophising Scale. Values in parentheses are standard
deviations.
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iance in ratings of impact, F = 17.91, p < 0.001. In Step
2 of the analysis, age was entered but did not contribute
significant variance. The three subscales of the PCS
were allowed to compete for entry in the next step of
the analysis, and only the rumination subscale met cri-
teria in the regression equation, F = 38.09, p <0 . 0 0 1 .
Rumination accounted for 36% of the variance in ratings
of FM impact beyond that accounted for by pain.
F o rG r o u pB ,p a i nw a se n t e r e di nS t e p1a n d
accounted for 25% of the variance in disability ratings, F
= 19.53, p < 0.001. When the three PCS scales were
allowed to compete in the next step of the analysis,
both magnification (F = 18.5, p <0 . 0 0 1 )a n dh e l p l e s s -
ness (F = 18.5, p < 0.001) met criteria for entry in the
regression equation, and they accounted for roughly the
same percentage of the variance (17% and 16%, respec-
tively) in ratings of impact when controlling for pain.
For Group C, pain was also entered in Step 1 and
accounted for 21% of variance, F =5 7 . 0 ,p <0 . 0 0 1 .T h e
helplessness subscale of the PCS was entered next
because it was the only one that met minimum criteria
for entry in the regression equation, F = 51.17, p <
0.001. It accounted for an additional 12% of the
variance.
Discussion
Most reviews of the current literature conclude that psy-
chological interventions in patients with FM are rela-
tively limited [8-10]. To improve treatment outcomes,
more evidence is needed from experimental and pro-
spective studies that examine the specific cognitive and
behavioural mechanisms responsible for the develop-
ment and maintenance of chronic pain and disability.
Such evidence would help treatment providers to
develop interventions tailored to a patient’s risk profile.
Although considerable research has been conducted to
elucidate the vulnerability factors associated with pain-
related disability, the role of vulnerability-relevant con-
textual factors has not been systematically investigated.
The purpose of the present study was to test the role
of FM impact in relation to a thinking process that
often accompanies, and appears to worsen, the experi-
ence of unremitting pain, namely, catastrophising, as a
function of stage of chronicity (i.e. number of years
since the FM diagnosis). From the current perspective,
the influence of catastrophising on FM impact was con-
sidered to be variable and dependent on the context
(i.e., duration of diagnosis) in which the catastrophising
thoughts occur.
Accordingly, the findings of the present study provide
preliminary evidence that the psychological correlates of
FM impact change over time. Specifically, regression
analyses revealed that stage of chronicity moderated the
relationship between the PCS subscales and FM impact.
In the group of patients who had been diagnosed with
FM for fewer than 2 years, rumination accounted for
significant unique variance in FM impact. Magnification
and helplessness predicted FM impact over and above
the variance accounted for pain severity for patients
who had been diagnosed for 2-4 years, and helplessness
was the strongest predictor of FM impact in the group
of patients diagnosed for more than 4 years.
Additionally, results are concordant with what was
expected. Patients who have suffered from FM for less
than 2 years are characterised by exaggerated threat
appraisals (rumination), which may contribute to the
Table 2 Correlations between PCS subscales and pain
and impact
Group Rumination Magnification Helplessness Total PCS
MPQ (pain)
A (< 2 years) 0.43** 0.44** 0.53** 0.50**
B (2-4 years) 0.27* 0.40** 0.47** 0.42**
C (> 4 years) 0.32** 0.23** 0.36** 0.34**
FIQ (impact)
A (< 2 years) 0.76** 0.63** 0.68** 0.73**
B (2-4 years) 0.48** 0.59** 0.58** 0.60**
C (> 4 years) 0.46** 0.38** 0.50** 0.50**
Group A (n = 46), Group B (n = 59), Group C (n = 223). MPQ = McGill Pain
Questionnaire; FIQ = Fibromyalgia Impact Questionnaire; PCS = Pain
Catastrophising Scale. * p < 0.05, ** p < 0.01.
Table 3 Prediction of FM impact for each stage of
chronicity
Predicting FM impact in Group A
Variables Beta RÂ² Pearson r
Step1 Pain 0.55** 0.30 0.55**
Step2 Pain 0.32** 0.66 0.81**
Rumination 0.61**
Predicting FM impact in Group B
Variables Beta RÂ² Pearson r
Step1 Pain 0.50** 0.25** 0.50**
Step2 Pain 0.28* 0.42** 0.64**
Magnification 0.45**
Step2 Pain 0.30* 0.41** 0.64**
Helplessness 0.44**
Predicting FM impact in Group C
Variables Beta RÂ² Pearson r
Step1 Pain 0.46** 0.21** 0.46**
Step2 Pain 0.30** 0.33** 0.58**
Helplessness 0.39**
The impact was measured with the Fibromyalgia Impact Questionnaire,
catastrophising with the Pain Catastrophising Scale and pain with the McGill
Pain Questionnaire. * p < 0.05, ** p < 0.01.
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to physical activity. In patients who have suffered from
FM for more than 4 years, helplessness appraisals may
accentuate the impact on function These results are also
in line with those of previous studies on chronic pain,
in which rumination was the best predictor of severity
of disability in patients who had been experiencing pain
for approximately 3 years [28], and helplessness was the
best predictor of severity in patients who had been
experiencing pain for approximately 9 years [29].
The present findings suggest that interventions that
consider stage of chronicity as a moderator of vulner-
ability for impact may yield more positive outcomes
than standardised approaches to the management of
FM. Cognitive therapies should be more focused on spe-
cific assessments (threat or helplessness) depending on
the context to optimise treatment outcomes These find-
ings also suggest that there is an additional facet to con-
sider with regard to the relationship between
catastrophising and FM impact, one that derives from a
contextual view of how thoughts will variably influence
behaviour dependent upon history, situation and, of
course, stage of chronicity.
Finally, it is notable that catastrophising was a stron-
ger predictor of FM impact than pain itself for the three
different stages of chronicity and that catastrophising
remained constant over time, despite the fact that FM
impact increased. These findings suggest that not only is
the type of intervention important but also the timing of
treatment. The findings accentuate the significance of
early detection and treatment of patients who are at risk
of developing FM and related problems [30]. Intervening
early in the course of a pain condition may help prevent
maladaptive patterns of pain coping and illness beha-
viours that are resistant to treatment, and it may have
the potential to reduce or prevent the negative impacts
of FM that, in turn, will reduce societal and medical
costs. It follows that early intervention is far more likely
to be effective than interventions administered in the
later stages of the condition. Psychological treatments
that are initiated shortly after a patient has been diag-
nosed with FM can help prevent long-term dysfunction
and chronicity.
As Sullivan has pointed out [21], the results of our
study are limited mainly because our correlational meth-
ods cannot unambiguously determine whether catastro-
phising leads to higher levels of FM impact or vice
versa. Given the consistent relationship between cata-
strophising and FM impact, however, it is clear that
there are important contextual processes at work.
Experimental, longitudinal, or clinical methods are
needed to illuminate these processes. A second limita-
tion of this study lies in the accuracy of the chronicity
classifications. One of the main difficulties that FM
patients face is failure to receive the FM diagnosis until
well after the onset of the disease. It is estimated that
there is a 3 year delay in the diagnosis of FM in Spain
[31]. Therefore, it is possible that some of the subjects
in this research who were classified as being in one of
the earlier stages of chronicity had actually been suffer-
ing from pain for some time previously. A final limita-
tion concerns the recruiting methods; because half of
the subjects were recruited from a specialised clinic, the
sample as a whole may not be representative of all
patients with FM.
Conclusion
The findings of this study highlight the important con-
tribution of contextual factors in prolonging the pain
condition, and as such, they have clinical implications
for the assessment of FM. The study of contextual
determinants of psychological vulnerability will play a
role in the development of tailored interventions. Recent
developments of Contextual Therapies aimed at pain
acceptance have shown that such therapies are relevant
in the treatment of chronic pain [32,33]. Based on these
preliminary but promising findings, we conclude that if
patients with FM were to be subdivided consistent with
their distinctive contextual cognitive and behavioural
patterns, and if interventions were subsequently modi-
fied to match these specific risk profiles, the efficacy of
psychological treatment programs could be substantially
advanced.
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